Activated umbilical cord mesenchymal stromal cells (UC-MSC) therapy is still receiving attention in 2026 for autism spectrum disorder because researchers are investigating whether induced uterine UC-MSC can help moderate selected patients with their immunomodulatory and anti-inflammatory effects. Simultaneously, the field remains investigational. A 2026 review presented in the Journal of Translational Medicine indicated nine registered […]
Search Diseases & Conditions....

